BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• miRagen Therapeutics Prices Public Offering of Common Stock

  In addition, the Company has granted the underwriters a 30-day option to purchase up to an additional 1,050,000 shares of common stock on the same terms and conditions.

  February 9, 2018

   · 

  6 min read
• Drug Development

  Aquinox Provides Enrollment Update for LEADERSHIP 301 Clinical Trial of Rosiptor

  The announcement was made as part of the company’s analyst and investor event held today in New York.

  February 9, 2018

   · 

  6 min read
• Business

  Novanta Schedules Earnings Release and Conference Call for Wednesday, February 28, 2018

  Novanta will release its fourth quarter and full year 2017 results on Wednesday, February 28, 2018.

  February 9, 2018

   · 

  1 min read
• Business

  Arrowhead Pharmaceuticals Reports Fiscal 2018 First Quarter Results

  The company is hosting a conference call at 4:30 p.m. EST to discuss results.

  February 9, 2018

   · 

  5 min read
• Deals

  Vaxart Provides Merger Update

  Vaxart announced today it has reached an understanding with the CAS Group under which East Hill, a major shareholder in Aviragen, will support the merger between Vaxart and Aviragen.

  February 9, 2018

   · 

  4 min read
• Business

  Dynatronics Schedules Conference Call to Report Financial Results for Second Fiscal Quarter

  Dynatronics today announced that its financial results for the quarter ended December 31, 2017 will be released post market close on Tuesday, February 13, 2018.

  February 9, 2018

   · 

  1 min read
• Business

  Novo Nordisk Files Annual Report With the SEC

  Novo Nordisk has filed its Annual Report 2017 on Form 20-F for the financial year 2017 with the SEC, incorporating by reference parts of the Novo Nordisk Annual Report 2017.

  February 9, 2018

   · 

  1 min read
• Business

  ImmuCell Announces Preliminary Financial Results for Fourth Quarter and Full Year 2017

  During the quarter ended December 31, 2017, total product sales increased by approximately $919,000 to $3.1 million compared to $2.2 million during the same period in 2016, an increase of 42%.

  February 9, 2018

   · 

  10 min read
• Business

  The Cooper Companies Announces Release Date for First Quarter 2018

  The Cooper Companies today announced it will release first quarter 2018 financial results on Thursday, March 8, 2018, at 4:15 PM ET.

  February 9, 2018

   · 

  1 min read
• Drug Development

  FDA Grants Orphan Drug Designation for Xeris Pharma’s Ready-to-Use Glucagon

  Xeris also announced the publication of a Phase IIa study of a mini-dose of its read-to-use glucagon in Post-Bariatric Hypoglycemia.

  February 9, 2018

   · 

  5 min read